Macrogenics reported $1.62B in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 198.95B 7.96B
Amgen AMGN:US $ 140.05B 3.22B
AstraZeneca AZN:LN 113.99B 18.86B
Biogen BIIB:US $ 52.13B 9.52B
Bristol Myers Squibb BMY:US $ 148.48B 7.52B
Cerulean Pharma CERU:US $ 93.27M 13.31M
Daiichi Sankyo 4568:JP 4662.17B 2197.51B
Dicerna Pharmaceuticals DRNA:US $ 2.87B 918.39M
Eli Lilly And LLY:US $ 220.12B 40.96B
Epizyme EPZM:US $ 847.42M 40.73M
Five Prime Therapeutics FPRX:US $ 1.77B 1.02B
Genmab GEN:DC 168.38B 31.59B
Geron GERN:US $ 449.18M 54.1M
Gilead Sciences GILD:US $ 86.36B 4.99B
Immunogen IMGN:US $ 1.32B 300.21M
Johnson & Johnson JNJ:US $ 433825.66M 1140.33M
Karyopharm Therapeutics KPTI:US $ 774.96M 14.69M
Macrogenics MGNX:US $ 1.62B 176.65M
Merk MRK:US $ 196918.18M 1780.24M
Mirati Therapeutics MRTX:US $ 8.31B 483.81M
Pfizer PFE:US $ 219205.69M 17108.81M
Puma Biotechnology PBYI:US $ 370.52M 20.79M
Regeneron Pharmaceuticals REGN:US $ 59.5B 8.81B
Seattle Genetics SGEN:US $ 28.65B 3.48B
Xencor XNCR:US $ 2.01B 489.02M